Novo's Ozempic, Wegovy picked for US Medicare price negotiations Healthcare & Pharmaceuticalscategory· January 17, 2025 The U.S. Food and Drug Administration approved Amgen's combination therapy ...
Amgen Inc. (AMGN) reported a profit for fourth quarter that decreased from the same period last year but beat the Street estimates.